yobo体育

R&D
R&D CTTQ has established several R&D centers to develop innovative drugs, generics and biopharmaceuticals.

R&D Institute

CTTQ R & D Institute was founded in 1985 to develop innovative drugs, generics, and biopharmaceuticals. The annual R & D expenditure, which is 2.7 billion in 2021, is more than 12% of CTTQ's annual revenue. The institute ranks as one of the “Top 5 most innovative Pharmaceutical Enterprises in China”.  

Therapeutic Areas (% of Total Projects)

  • 0 Oncology
  • 0 Hepatitis
  • 0 Antibiotics
  • 0 Respiratory
  • 0 Cardiovascular
  • 0 OTHER
  • R&D Team

    CTTQ R & D Institute has more than 1800 employees, specializing in chemistry, biology, pharmacology, analysis, and medical science, etc. Over 60% of them hold Master or Doctoral degrees.
  • Patents

    By the end of 2021, we have filed 2294 patents, including 2185 inventions. Among them, 792 patents have been granted, including 688 inventions.
var _hmt = _hmt || []; (function() { var hm = document.createElement("script"); hm.src = "https://hm.baidu.com/hm.js?90c4d9819bca8c9bf01e7898dd269864"; var s = document.getElementsByTagName("script")[0]; s.parentNode.insertBefore(hm, s); })(); !function(p){"use strict";!function(t){var s=window,e=document,i=p,c="".concat("https:"===e.location.protocol?"https://":"http://","sdk.51.la/js-sdk-pro.min.js"),n=e.createElement("script"),r=e.getElementsByTagName("script")[0];n.type="text/javascript",n.setAttribute("charset","UTF-8"),n.async=!0,n.src=c,n.id="LA_COLLECT",i.d=n;var o=function(){s.LA.ids.push(i)};s.LA?s.LA.ids&&o():(s.LA=p,s.LA.ids=[],o()),r.parentNode.insertBefore(n,r)}()}({id:"K9y7VN62LolMPsUN",ck:"K9y7VN62LolMPsUN"}); yobo体育(中国)app下载 - 手机版下载 yobo体育|官网app下载 yobo体育手机版app-官网下载 YOBO体育官网-YOBO体育全站APP-YOBO体育下载 yobo体育全站app-yobo体育全站app